Harpreet has 15+ years of experience as a Research and Development leader in fast-paced industrial settings across the pharmaceutical, biotechnology, cannabis and emerging psychedelic sectors. She founded Rudra Solutions Inc a year ago and currently also holds the position of Vice President, Research at PharmAla Biotech. As Vice President of Research at PharmAla, Harpreet oversees the chemistry, manufacturing and pre-clinical research to advance MDMA and the MDXX series of molecules and is responsible for identifying new analogues of MDMA that retain the efficacy but have a substantially improved safety profile.
Harpreet holds a B.Pharm and MTech from the Institute of Chemical Technology in India and a PhD in Biochemical Engineering from the University of Western Ontario, Canada. Her work experience spans prominent pharmaceutical and Cannabis companies, such as Sun Pharma, IPCA Laboratories, Biocon Ltd. and Tilray Brands Inc.